TG Therapeutics | Vinst Före Skatt



Pre Tax Profit Ändra Datum
AbbVie USD 4.81B 1.54B 2024-12
Alaunos Therapeutics USD -7843000 633K 2023-12
Amgen USD 3.38B 111M 2024-12
Ardelyx USD 4.68M 5.45M 2024-12
Arrowhead Research USD -175115000 2.32M 2024-12
Bayer EUR -481000000 805M 2024-12
Biogen USD 572.2M 118.5M 2024-12
Corcept Therapeutics USD 161.49M 108.55M 2024-12
Dynavax Technologies USD 7.63M 12.19M 2024-12
Gilead Sciences USD 2.96B 112M 2024-12
J&J USD 5.42B 1.86B 2024-12
Novartis USD 4.66B 269M 2024-12
PTC Therapeutics USD -97991000 12.26M 2024-09
Regeneron Pharmaceuticals USD 958.1M 534.9M 2024-12
Roche Holding CHF 1.78B 2.33B 2024-12
TG Therapeutics USD 25.45M 21.18M 2024-12
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12



TG Therapeutics Vinst Före Skatt - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Mar 2025.